This bill modifies tax rules for vaccines by adding new vaccines to the list of taxable vaccines under federal law. Specifically, it includes any vaccine placed on the Vaccine Injury Table under the Public Health Service Act, which determines eligibility for compensation for vaccine-related injuries. Manufacturers and distributors will need to account for these vaccines under the tax code once HHS adds them to the injury compensation list. The change affects tax reporting for these specific vaccines but does not alter vaccine access, costs, or the injury compensation program itself.
The PAATCH Act amends Medicare rules to preserve "sole community hospital" designations for specific hospitals. It extends the timeframe for hospitals that met certain requirements before March 13, 2020, to maintain their designation for a 5-year period starting when the bill becomes law. This applies directly to community hospitals currently recognized under this Medicare classification. The bill changes the existing rule by adding a new provision (subclause IV) to the Social Security Act, ensuring these hospitals retain their status without needing to reapply during the extended period. It does not create new hospital designations or alter Medicare payment rates.
This bill prevents Medicare from imposing stricter supervision requirements for outpatient physical therapy and occupational therapy than those established by state law, requiring Medicare to follow existing state regulations instead. It takes effect January 1, 2024, directly affecting Medicare-covered therapy services in all states. Additionally, it mandates a Government Accountability Office study by December 2024 to analyze how Medicare’s 15% payment differential for therapy assistants impacts access to care in rural and underserved areas. The study will examine this payment policy across all Medicare Part B settings.
HR 4752 (the CHANGE Act of 2023) requires Medicare to include standardized cognitive impairment screening during annual wellness visits and initial preventive physical exams for beneficiaries starting in 2024. It mandates doctors use National Institute on Aging-approved tools to detect memory issues and document results in medical records. This directly affects Medicare patients aged 65+ and their healthcare providers, aiming to enable earlier Alzheimer’s diagnosis and care planning. The bill focuses on making routine screenings a standard part of Medicare-covered checkups, not on funding or new programs. It does not alter existing Medicare benefits but adds a specific screening requirement to two existing service categories.
This bill mandates an interagency review by the Department of Health and Human Services (with Defense and Veterans Affairs) to address lung cancer disparities affecting women. It requires a report evaluating research gaps, improving access to lung cancer screening (especially for underserved groups), and developing public awareness campaigns about early detection. The review will focus on factors like environmental exposures, genomic differences, and treatment responses specific to women, particularly those who never smoked. The report must be submitted to Congress within one year of enactment. This directly affects women at risk of lung cancer, including those with non-smoking-related cases.
This bill expands Medicare coverage to include home infusion treatment for people with Alpha-1 Antitrypsin Deficiency Disorder, a genetic condition causing lung and liver damage. It specifically covers "augmentation therapy" (a standard treatment using Alpha-1 Proteinase Inhibitor) when administered in a patient's home by qualified providers. Medicare will pay 80% of the cost for intravenous kits and up to 2 hours of nursing care during these home infusions, starting January 1, 2025. The change directly affects Medicare beneficiaries with this condition who require home-based treatment and their qualified home infusion providers.
This bill prohibits Medicare from paying for certain custom-fitted or custom-fabricated orthotic and prosthetic devices delivered via "drop shipment" (direct shipping without in-person training from a qualified provider). It directly affects Medicare beneficiaries who need these devices, ensuring they receive necessary in-person fitting and training. The bill also expands which healthcare professionals (including physical therapists, occupational therapists, orthotists, and prosthetists) can prescribe these devices and updates definitions to clarify terms like "orthoses" and "prostheses." Final regulations implementing these changes must be issued within one year of the bill's enactment.
The ARC Act of 2023 establishes a national program to address peripheral artery disease (PAD), which disproportionately affects minority populations and leads to avoidable amputations. The bill requires Medicare and Medicaid to cover PAD screening tests (such as ankle-brachial index testing) for at-risk beneficiaries without cost-sharing, including people 65+ or those with diabetes, smoking history, or other risk factors. It authorizes $6 million annually for a CDC-led education program to inform healthcare providers and the public about PAD prevention and treatment. The bill also creates quality measures to encourage alternative treatments to amputation and establishes a pilot program to test amputation prevention services at healthcare facilities. These provisions aim to reduce amputation rates and improve outcomes for millions of Americans with PAD.
The CONNECT for Health Act of 2023 aims to expand access to telehealth services under Medicare by removing barriers that previously limited who could provide these services and where they could be delivered. The bill eliminates geographic restrictions on telehealth coverage, allows telehealth services to be provided from the patient's home and other clinically appropriate locations, and expands the types of healthcare providers who can offer telehealth services. It also improves the process for adding new telehealth services to Medicare coverage and includes provisions to ensure quality measurement includes telehealth services. This legislation directly affects Medicare beneficiaries seeking remote care and healthcare providers delivering telehealth services, with key provisions taking effect between 2024 and 2025.
This bill amends Medicare rules to improve access to home infusion therapy, which delivers IV medications at home for conditions like chronic diseases. It adds pharmacy services (including drug preparation and compounding) to covered Medicare benefits and creates a payment rule: if a supplier isn't physically present during therapy, Medicare pays 50% of the full rate instead of denying payment. It also allows nurse practitioners and physician assistants to establish and review home infusion care plans, previously limited to physicians. These changes, effective January 2024, directly affect Medicare beneficiaries requiring home infusion therapy and providers delivering these services.
HR 4034 would add cranial prostheses (such as medical wigs) to Medicare's list of covered durable medical equipment. It requires a dermatologist, oncologist, or attending physician to certify in writing that the prosthesis is medically necessary as part of rehabilitative treatment. This change directly affects Medicare beneficiaries experiencing hair loss due to medical conditions like cancer treatment who need these prostheses for health reasons. The bill does not cover cosmetic wigs but specifically targets medically necessary cranial prostheses under existing Medicare coverage rules.
HR 3875, the Expanded Telehealth Access Act, expands Medicare coverage for telehealth services by adding new healthcare professionals to the list of providers eligible for payment. It specifically includes licensed audiologists, occupational therapists (and their assistants under supervision), physical therapists (and their assistants under supervision), and speech-language pathologists. The bill ensures these providers are paid the same rate for telehealth services as they would be for in-person care under Medicare. This change directly affects Medicare beneficiaries seeking remote therapy services and the new provider types who can now offer these services via telehealth.
